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In many cell types, the mitogen-activated protein kinase (MAPK) also named extracellular signal-regulated kinase (ERK) is
activated in response to a variety of extracellular growth factor-receptor interactions and leads to the transcriptional activation
of immediate early genes, hereby inﬂuencing a number of tissue-speciﬁc biological activities, as cell proliferation, survival and
diﬀerentiation. In one speciﬁc cell type however, the female germ cell, MAPK does not follow this canonical scheme. In oocytes,
MAPKis activated independently ofgrowth factors and tyrosinekinase receptors, acts independently of transcriptional regulation,
plays a crucial role in controlling meiotic divisions, and is under the control of a peculiar upstream regulator, the kinase Mos. Mos
wasoriginallyidentiﬁedasthetransforminggeneofMoloneymurinesarcomavirusanditscellularhomologuewastheﬁrstproto-
oncogene to be molecularly cloned. What could be the speciﬁc roles of Mos that render it necessary for meiosis? Which unique
functions could explain the evolutionary cost to have selected one gene to only serve for few hours in one very speciﬁc cell type?
This review discusses the original features of MAPK activation by Mos and the roles of this module in oocytes.
1.Introduction
In many cell types, the mitogen-activated protein kinase
(MAP kinase/MAPK) also named extracellular signal-
regulated kinase (ERK) is activated in response to a variety
of extracellular growth factor-receptor interactions at the
cell surface and leads to the transcriptional activation of
immediate early genes. Brieﬂy, tyrosine kinase receptors
and p21Ras recruit the Ser/Thr kinase Raf-1 that activates
MEK (MAP/ERK kinase), which in turn phosphorylates and
activates MAPK, hereby inﬂuencing a number of tissue-
speciﬁc biological activities in diverse cell types, as cell
proliferation,survival,anddiﬀerentiation.Inonespeciﬁccell
type, however, the female germ cell, MAPK does not follow
this canonical scheme. In oocytes, MAPK is activated inde-
pendently of growth factors and tyrosine kinase receptors,
acts independently of transcriptional regulation, controls the
G2-M period of the cell cycle and not the G1-S transition,
and is under the control of a peculiar upstream regulator
called Mos.
In the early 1980s, Mos was originally identiﬁed as
the transforming gene of Moloney murine sarcoma virus
(v-mos) causing cellular transformation [1–3]. Its cellular
homologue was the ﬁrst proto-oncogene to be molecu-
larly cloned. When ectopically expressed, the c-mos proto-
oncogene product Mos induces oncogenic transformation of
somaticcells[1].MosisaSer/Thrkinasewhosetransforming
activity strictly depends on its kinase activity. Given this
activityasanoncoprotein,itsexpressionpatternwassurpris-
ingly restricted to germ cells. In frogs, birds, and mammals,
very low concentrations of c-mos transcripts were detected
in brain and testes, but a high level was observed in ovaries,
restricted to oocytes [4–6]. The Mos protein is expressed
even in a much more restricted manner than its transcripts,
both temporally and spatially at a very speciﬁc place: it
accumulates during the oocyte meiotic divisions and under-
goesselectiveproteolysisuponfertilizationinalleumetazoan
except the nematode Caenorhabditis elegans where the gene
is absent [4, 7–9]. It has to be noted that in mouse and
the jellyﬁsh Clytia hemispherica, Mos is also expressed in2 Journal of Signal Transduction
developing spermatids [8–10]. This unique pattern of Mos
expression strongly suggested that its function is restricted
to meiosis. This hypothesis was conﬁrmed in 1988-1989
by a series of pioneer articles of Noriyuki Sagata, George
Vande Woude, and their collaborators who proposed that
in the frog oocyte, Mos would be an essential regulator
of the universal eukaryotic inducer of M-phase of the cell
cycle, MPF (M-phase promoting factor), responsible for
reinitiation of meiotic division. MPF is a dimer formed of a
catalytic subunit, the Cdk1 kinase (cyclin-dependent kinase
1) and of a regulatory subunit, cyclin B. Mos would serve
to activate MPF for entry into the ﬁrst meiotic division, but
also to stabilize MPF during the second meiotic division,
inducing the arrest of oocyte that awaits sperm entry [7,
11, 12]. Later, the ﬁrst function of Mos as an activator of
MPF and an initiator of oocyte meiotic entry was not found
to be conserved in all animal species whereas its role in
postmeiotic arrest turned out to be well conserved: Mos
holds in check the unfertilized oocyte arrest. This arrest is
characteristic of the entire animal kingdom and is critical for
the embryonic development as it allows the mature oocyte to
await fertilization, preventing the continuation of cell cycles
after meiosis and parthenogenetic development. The target
of Mos was discovered few years later. In oocytes, Mos is the
upstream activator of MAPK which functions through direct
phosphorylation of MEK. Therefore, this original signaling
module, Mos/MEK/MAPK, is a critical regulator of some
of the most important cell divisions in our life: the meiotic
divisions that produce the egg.
At ﬁrst glance, the physiological meiotic functions of
Mos appear to be strikingly diﬀerent from the oncogenic
properties of the kinase in somatic cells. The loss of Mos
in mouse leads to parthenogenesis and to the development
of ovarian teratomas [13, 14], consistent with the idea that
mos could be considered as a meiotic tumour-suppressor
gene whereas its activity as an oncoprotein is well established
in somatic cells. This opens the question of the apparently
conﬂicting eﬀects of the Mos protein, namely, its ability to
induce M-phase entry of oocytes, to arrest mitotic cleavage
of Xenopus unfertilized oocyte and to transform mammalian
ﬁbroblasts. Another question arises from the observation
that the functions of Mos in the female germ cell appear
to be largely mediated by MAPK. In the animal oocytes,
Mos is a MAPKKK, equivalent to the proto-oncogene Raf-
1. Although Raf-1 is expressed in oocytes, Mos is selected to
activate the MAPK module during meiotic divisions. What
could be the speciﬁc roles of Mos that render it necessary for
meiosis and that cannot be played by Raf-1? Which unique
functionscouldexplaintheevolutionarycosttohaveselected
one gene to only serve for few hours in one very speciﬁc
cell type? This paper discusses the original features of MAPK
activation by Mos and the roles of this module in oocytes.
2. Biochemical Properties and Evolution of Mos
In human, mouse, and chicken, the c-mos genomic locus
contains only a single coding exon corresponding to a poorly
conserved src homology sequence that yields a protein of
39kDa. There are two types of conserved regions among
Mos proteins: those conserved among all members of the src
kinase family that are important for maintaining the basic
structure for kinase activity and those conserved only among
the Mos proteins [6]. The mutations of Mos that cause the
loss of its kinase activity (e.g., substituting an arginine for
the conserved lysine residue (K90) found in the ATP-binding
site) abolish all its biological functions, meiotic induction,
meioticeggarrest,andtransformingactivity[15,16].Several
studies have revealed the contribution of some regions of the
sequence to Mos functions, as the helix C laying in the kinase
domain whose orientation could govern Mos kinase activity
[17, 18]. Mutagenic analysis outside the kinase domain
showed that the cytoplasmic localization of the protein is
important for its biological activity, as the deletion of a 10
amino acids region required for nuclear localization greatly
enhances the transforming activity of Mos [19]. Mos also
exhibits an in vitro DNA-binding activity [20] that seems not
to be required for any of its biological functions.
2.1. V-Mos versus C-Mos. Mos was originally identiﬁed as
the transforming gene of Moloney murine sarcoma virus
of which several viral isolates have been characterized [1,
3, 21]. Sequence comparison of diﬀerent v-Mos proteins
with murine c-Mos revealed the presence of additional
31 amino acids at the N-terminus of the v-Mos proteins
derived from the viral env gene and from an upstream
extension of the c-mos open reading frame. Apart from
this N-terminal extension, the amino acid sequences of v-
Mos and c-Mos either are identical or diﬀer in few amino
acids, depending on the viral strains [3, 18]. In vivo,b o t h
c-Mos and v-Mos are able to cause oocyte maturation,
meiotic oocyte arrest, and transformation of somatic cells
[22,23].Interestingly,Mosgenesareabletotransformmouse
N I H3 T 3c e l l swi t hm a r k e d l yd i ﬀerent eﬃciencies depending
on the species but not related to the viral origin of the
gene: v-Mos and mouse and chicken c-Mos are equally
eﬃcient but more than human and Xenopus c-Mos [16].
In vitro, v-Mos is able to autophosphorylate whereas in
parallel experiments c-Mos is not, suggesting a correlation
between the transforming activity of v-Mos and its ability to
autophosphorylate. However, several point mutations in v-
Mos resulted in mutants retaining transforming activity but
lacking autophosphorylating activity,showing thefunctional
uncoupling of autophosphorylation and transformation
ability[17,24].Insummary,c-Mosandv-Mosdonotexhibit
very striking diﬀerences in both sequences and cellular
activities.
2.2. Mos Is a MAPKKK. Given the critical role played
by Mos in animal oocyte meiosis and its oncogenic
properties, the identiﬁcation of its targets was of prime
importance. In 1993, several laboratories discovered that in
Xenopus oocytes, oocyte extracts and mammalian cultured
cells, either endogenous or exogenous Mos can activate
MAPK by directly phosphorylating and activating MEK1,
an immediate upstream activator of MAPK [25–28]. The
two amino acids phosphorylated by Mos in MEK areJournal of Signal Transduction 3
identical to those phosphorylated by Raf-1 [29, 30]. Inside
the Mos/MEK/MAPK module, both activation reactions
(the phosphorylations of MEK and MAPK) require two
phosphorylations on the downstream kinase, producing a
cascade in which the activity of MAPK varies as a fourth
power of the activity of Mos, so that a modest increase
in Mos, as doubling its activity, changes the activity of
MAPK from 10% to 90%. The Mos/MAPK cascade is,
therefore, ultrasensitive, explaining how the activation of
MAPK switches from oﬀ to on in response to the minute
amount of viral Mos protein present in transformed mouse
cells (0.0005% of total protein) or in Xenopus matured
oocytes (200pg or 0.001% of total protein), accounting for
the all-or-none character of this cell fate switch [7, 31].
However, during Xenopus oocyte maturation, progesterone
induces the synthesis of Mos before MPF activation whereas
MAPK, which preexists in immature oocytes is activated at
time of MPF activation, that is one or two hours after Mos
synthesis has begun [7, 25, 32]. This observation is diﬃcult
to reconcile with the all-or-none and ultrasensitive response
ofMAPKactivationtolowamountsofMos.Itispossiblethat
initialsynthesizedMosiskeptatatoolowleveltoactivatethe
cascade, until its stabilization is achieved by MPF and allows
the formation of suprathreshold levels required for turning
on the MEK/MAPK module [33].
2.3. Other Substrates for Mos? Other proteins have been
proposed to be direct targets for Mos since they can be
phosphorylated by Mos in vitro. Among them is cyclin B2,
the main Cdk1 partner forming the pre-MPF complexes
in Xenopus immature oocytes. Cyclin B phosphorylation
by Mos has been proposed to be necessary for activation
of MPF kinase during Xenopus oocyte maturation and
to prevent degradation of cyclin B during the meiotic
arrest [34], a model that has never been experimentally
proved. Mos has also been described as a tubulin-associated
protein kinase [35–37].Interestingly,inoocytesfrommouse,
Xenopus, starﬁsh, and the jellyﬁsh Clytia hemispherica,M o s
activity is required for the correct formation and peripheral
positioning of the meiotic spindle [8, 9, 38, 39]. Mos is
also localized on mitotic spindle and spindle pole regions in
Mos-transformed NIH/3T3 cells [35, 36]. The tubulin kinase
activity of Mos could thus participate in the modiﬁcation of
microtubules and contribute to the formation of the spindle.
However, it is not known whether these in vitro substrates do
mediate the physiological functions of Mos. It has also been
proposed that in mouse oocytes, Mos would contribute to
MAPK activation not only through MEK activation but also
through the inhibition of an unidentiﬁed phosphatase [40],
an interesting observation that has not been noted in other
species until now.
2.4. Mos Evolution. For more than 20 years, the studies on
Mos have been conducted in vertebrates, mainly mouse,
human, birds, and frogs. In the entire animal kingdom,
to maintain ploidy through successive generations, meiosis
must be followed by mitosis after the recovery of diploidy
by fertilization. The coordination from meiotic to mitotic
cycle is ensured by a meiotic arrest of the oocyte, while the
cell awaits fertilization. This arrest occurs at metaphase of
the second meiotic division (metaphase II) in vertebrates
whereasthe stage of oocyte meiotic arrest is variable in inver-
tebrates. It was clearly established in vertebrates that Mos is
essential to arrest oocyte meiotic divisions at metaphase II,
leading to thehypothesis thatMos isa molecularregulatorof
MPF and the M-phase of the cell cycle. For this reason, it was
assumed that Mos functions only in vertebrate oocytes, until
Tachibana and his collaborators isolated the ﬁrst invertebrate
Mos from starﬁsh and demonstrated that it is essential for
the natural arrest of the echinoderm unfertilized egg, in G1
phase after completion of meiotic divisions [8]. These results
changed the view on the role of Mos. It is not restricted
to the maintenance of the metaphase II arrest but more
broadly prevents the meiotic/mitotic conversion by arresting
theunfertilizedoocyteatvariousstagesofmeiosisdepending
on species. The proposal of a conserved role of Mos in
invertebrate and vertebrate oocytes was then questioned by
the observation that the mos gene is absent in the nematode
Caenorhabditis elegans genome and that the Drosophila Mos
ortholog is not essential for meiosis [41]. However, in the
sawﬂy, where Mos has also been characterized, it mediates
the physiological metaphase I arrest characterizing the insect
oocytes [42]. A recent phylogenetic survey reconciled these
data by demonstrating that Mos appeared early during
animal evolution as an oocyte-expressed kinase and func-
tioned ancestrally in regulating core specializations of female
meiosis [9]. Unexpectedly, cnidarian genomes contain more
than one mos gene after ancestral duplications, in contrast
with bilaterians, in which only one single gene is found.
Changes in the characteristics of oogenesis probably explain
this diversiﬁcation of mos genes and their related functions
in cnidarians. All genomes from eumetazoan (bilaterian +
ctenophore + cnidarian) species examined by Amiel et al.
[9] contained mos gene orthologs, showing well-conserved
kinase domains, with the exception of C. elegans where the
gene was secondarily lost. Mos genes were not detected in
available sponge (Amphimedon), choanoﬂagellate, or fungi
genomes, suggesting that the gene may have originated in a
commoneumetazoanancestor[9].Thus,Moskinasesshould
be seen not as core regulators of meiosis, which is a much
older process than Mos origin, but of a particularity of
meiosisineumetazoan.Whichinnovationsofoocytemeiotic
divisions relate to mos gene evolution have to be investigated.
3.Oocyte MeioticMaturation:The Unique
Physiological ProcessunderMos Control
In the animal kingdom, the oocytes growing in the ovaries
are arrested at prophase of the ﬁrst meiotic division that
resembles a G2-phase of the cell cycle. These immature
oocytes require a physiological stimulus to undergo meiotic
maturation: the progression through the meiotic divisions
that converts them into fertilizable oocytes, again arrested at
variousstagesofmeiosisandawaitingfertilization(Figure1).
Indeed, the embryonic development cannot begin until
completion of the female germ cell meiotic divisions. This4 Journal of Signal Transduction
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Figure 1: Progression through meiosis and timing of fertilization: what does Mos do? Oocytes are arrested at prophase of the ﬁrst meiotic
division(prophaseI).Underresponsetoaphysiologicalstimulus,MPFisactivatedandpromotesbreakdownofthenuclearenvelope(GVBD
for germinal vesicle breakdown) and formation of the metaphase I spindle. In insects, molluscs, and ascidians, oocytes arrest at metaphase
I until fertilization. In the other cases, oocytes extrude the ﬁrst polar body and enter the second meiotic division. In vertebrates, they arrest
at metaphase II until fertilization. In echinoderms and cnidarians, they complete the second meiotic division by emitting the second polar
boy, reform a nucleus (female pronucleus), and stop at the G1 phase of the ﬁrst cell cycle until fertilization. In diﬀerent species including the
nematode Caenorhabditis elegans, fertilization occurs at prophase I and corresponds to the stimulus promoting meiotic maturation. Mos has
been implicated: (i) in the initial step of MPF activation during reinitiation of meiotic division, (ii) during the metaphase I to metaphase II
transition for the suppression of S-phase, for the microtubular spindle organization and for the reactivation of MPF to enter meiosis II, and
(iii) in the arrest of oocyte maturation before fertilization.
temporal coupling is ensured by the arrest of meiotic
divisions of the oocyte that depends on a biological activity
called CSF (for cytostatic factor) [43, 44]. The CSF arrest
is released by fertilization. Oocytes arrest at metaphase
I in insects, molluscs and ascidians and at metaphase
II in vertebrates. In echinoderms and cnidarians, oocytes
complete meiosis and arrest in G1 (and are then called
“eggs” in these species, as they completed meiotic divisions).
In diﬀerent species including the nematode Caenorhabditis
elegans, fertilization occurs at prophase I and corresponds to
the stimulus promoting meiotic maturation. Except for this
lastcase,thestimuliformaturationareprovidedatovulation
by the follicular cells surrounding the oocyte. The signals
are very diﬀerent from species to species: steroid hormones
in frogs and ﬁshes, modiﬁed purines in starﬁsh, removal of
a follicular inhibitor in mammals, but all activate signaling
pathways that converge to the same target, independently
of transcription: the activation of the universal eukaryotic
inducer of M-phase, MPF, a complex formed of the Cdk1
kinase, and Cyclin B. Once activated, MPF promotes entry
into the ﬁrst meiotic division: breakdown of the nuclear
envelope (known as GVBD for germinal vesicle breakdown)
and formation of the metaphase I spindle (Figures 1 and
2). MPF activity falls during anaphase I, due to partial
cyclin B degradation, and rises again leading to entry into
meiosis II. Importantly for the generation of proper haploid
gametes, DNA replication does not occur between both
meiotic divisions. The need for the Mos/MAPK cascade
during oocyte meiotic maturation has been debated for
decades (Figure 1). First, Mos has often been implicated
in the initial step of MPF activation during reinitiation of
meiotic division, especially in the frog oocyte. Second, Mos
has been shown to be required during the metaphase I to
metaphase II transition for the suppression of S-phase and
for the reactivation of MPF after meiosis I, thus enabling the
oocyte to enter meiosis II. Third, a universal role of Mos is
to prevent parthenogenesis by arresting oocyte maturation
at the various stages depicted in Figure 1, allowing them to
await fertilization. Mos is therefore a key regulator of meiosis
in the animal kingdom.
4. Regulation of Mos Activity
Mos protein functions as a kinase in a meiosis-speciﬁc
manner in animal oocytes. In Xenopus, Mos gene is actively
transcribed in the grownup oocytes where its message is
abundant [6]. However, oocytes arrested at prophase I
lack detectable levels of Mos. The synthesis of the pro-
tein is induced in response to the physiological stimulus
that promotes reentry into meiotic divisions, Mos protein
then accumulates throughout meiotic maturation, is stably
maintained in the mature oocyte, and is ﬁnally degraded
at fertilization (Figure 2). This unique pattern of Mos
expression, accounting for its restricted function during
oocyte meiosis, is clearly under a tight translational and
proteolysis control.
4.1. Translational Control of Mos. Many studies have been
devoted to the regulation of translation of maternally storedJournal of Signal Transduction 5
mRNAs during meiosis resumption of Xenopus oocytes. In
prophase-arrested oocytes, translation is repressed. Proges-
terone, the physiological inducer of meiotic divisions in
Xenopus, induces the ordered translation of mRNAs based
on polyadenylation events. This translational regulation
depends on regulatory elements within the 5  and 3 
untranslated regions (UTRs) of target mRNAs which are
recognized by sequence-speciﬁc RNA protein complexes to
mediate translational control [45, 46].
In immature Xenopus oocytes, the kinase TOR (target
of rapamycin) controls the translation of RNAs through a
5 TOP (terminal oligopyrimidine) sequence that contributes
to suppress translation of other RNAs, including Mos
mRNA, until hormonal stimulation of maturation [47]. The
translationalinductionofthedormantmRNAencodingMos
occurs 2 to 3 hours after stimulation by progesterone, before
MPFactivation[7,12](Figure2).The3 endpolyadenylation
o fM o sm R N Aa n da5  end modiﬁcation, cap-speciﬁc 2 -O-
methylation, were shown to be pivotal regulatory steps for
translational recruitment and for the progression of Xenopus
oocytes through meiosis [48, 49]. Cytoplasmic polyadenyla-
tion requires two sequences in the 3 UTR of Mos mRNA, the
U-rich cytoplasmic polyadenylation element (CPE) and the
near-ubiquitous polyadenylation hexanucleotide AAUAAA
recognized by the multifactor complex CPSF (cleavage and
polyadenylation speciﬁcity factor). CPE is recognized by
a group of factors among them the two most important
are CPEB, the CPE-binding factor, and Maskin [50–52]. In
oocytes, Maskin also binds eukaryotic translation initiation
factor 4E (eIF4E), an interaction that excludes eIF4G and
prevents formation of the eIF4F initiation complex [51].
It has been proposed in Xenopus that an early site-speciﬁc
phosphorylation of CPEB, possibly catalyzed by the Aurora-
A kinase [53], would be essential for the polyadenylation of
Mos mRNA by the poly(A)polymerase. Once cytoplasmic
polyadenylation has been promoted by CPEB, the newly
elongated poly(A) tail becomes bound by poly(A)-binding
protein (PABP), which in turn binds eIF4G and helps to
displace Maskin from eIF4E, thereby inducing translation
[51, 52]. Polyadenylation requires two factors, symplekin, a
CPEB- and CPSF-binding protein that serves as a scaﬀold
upon which regulatory factors are assembled, and xGLD-2,
anunusualpoly(A)polymerasethatisanchoredtoCPEBand
CPSF even before polyadenylation begins [54].
However, several ﬁndings refute the hypothesis that CPE
sequences and CPEB alone could account for the range of
temporal inductions of maternal mRNAs, including Mos
mRNA, observed during Xenopus oocyte maturation [55].
Polyadenylation and mRNA translational activation of Mos
are also controlled by a distinct CPE-independent mecha-
nism that depends on a 3 UTR polyadenylation response
element (PRE) [55, 56]. This translational activation is
mediated by the transacting factor Musashi that binds to the
PRE of mos mRNA [56, 57]. As CPEB, Musashi would also
be essential for Mos translational activation during Xenopus
oocyte meiotic maturation [58]. Several reports suggest that
mRNA translation directed by CPE is a late event that
would require early Musashi-dependent mRNA translation,
implying that Musashi function is necessary to establish
the temporal order of maternal mRNA translation during
meiotic progression [57–59]. It is, therefore, still diﬃcult
to get a clear picture of the signaling events that trigger
Mos mRNA polyadenylation and translation in the Xenopus
oocyte.
Interestingly, MAPK can stimulate Mos synthesis in
Xenopus oocyte, creating a positive feedback loop. Microin-
jection of activated forms of MEK or MAPK is suﬃcient
to stimulate Mos mRNA polyadenylation and translation
[60, 61] whereas inhibition of MAPK activation prevents
Mos accumulation [62]. MAPK activity could contribute
to CPEB phosphorylation and activation [63], but the
precise mechanism allowing this kinase to stimulate the
polyadenylation of Mos mRNA is still elusive.
In starﬁsh, rat, and mouse, the synthesis of Mos is also
initiated in maturing oocytes, except that it accumulates
only after MPF activation and the ﬁrst meiotic reentry
[8, 64, 65] (Figure 2). This noticeable diﬀerence in the
translational timing of Mos mRNA in mouse and starﬁsh
oocytes compared to Xenopus oocyte, explains why Mos is
not involved in the activation of MPF and the entry into the
ﬁrst meiotic division in these species [8, 13, 14, 38], a not-
so-surprising result given that this process does not depend
on protein synthesis. Similarly to the translational regulation
described in the Xenopus oocyte, mouse Mos mRNA is under
the translational control of cytoplasmic polyadenylation, a
necessary event for the oocyte progression to meiosis II after
the ﬁrst polar body emission. Cytoplasmic polyadenylation
of Mos mRNA in murine oocyte requires three cis elements
inthe3  UTR,thepolyadenylationhexanucleotideAAUAAA,
and two CPEs [66]. The biochemical events that govern
polyadenylation in mouse oocytes are not well known, but
they also involve CPEB whose activity is controlled by
Aurora-catalyzed phosphorylation, similarly to the Xenopus
situation [67–69].
Interestingly, one of the two Mos paralogs of the jellyﬁsh
Clytia hemispherica is subject to diﬀerential translational
regulation, being expressed during the growth period of
oogenesis, before meiotic maturation, perhaps under the
control of the TOR pathway [9]. This raises the attractive
possibility that Mos may have acquired new roles during
evolution after sequence changes in the UTRs aﬀecting
translational timing [70, 71]. Acquisition of a 5 TOP
sequence in one Clytia paralog may have resulted in an
earlier translational timing of this paralog compared to the
other one, leading to functions during the oocyte growth
period preceding meiotic maturation. In Xenopus,3  UTR
changes, such as an early acting Musashi PRE, could have
resulted in the temporal advancement of Mos translation
before MPF activation, explaining its atypical participation
in MPF activation and initiation of oocyte maturation. In
contrast, the translational activation of the human Mos
3  UTR is uniquely dependent on a late acting CPE-
dependent process [59]. Mos 3 UTR regulatory diﬀerences,
therefore, underlie species-speciﬁc temporal patterns of Mos
mRNA translational recruitment during oocyte maturation
and hence diﬀerent temporal windows for its functions,
oﬀering it the possibility to regulate MPF activation, or
not.6 Journal of Signal Transduction
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Figure 2: Patterns of Mos expression and MPF activity during oocyte meiotic maturation and at fertilization in Xenopus,m o u s e ,a n d
starﬁsh. Prophase I-arrested oocytes require a physiological stimulus to undergo meiotic maturation: progesterone in frogs, release from
the follicle in mammals, and 1-methyl-adenine in starﬁsh. Once activated, MPF promotes entry into the ﬁrst meiotic division: breakdown
of the nuclear envelope (GVBD for germinal vesicle breakdown) and formation of the metaphase I spindle (MI). MPF activity falls due
to partial cyclin degradation at meiosis I/meiosis II transition or interkinesis (IK), during which chromosomes remain condensed without
nuclear membranes and in the absence of DNA replication. MPF rises again leading to entry into meiosis II. In vertebrates, oocytes arrest
at metaphase II (MII), while in echinoderms, oocytes complete the second meiotic division and arrest at the G1 phase. Mos translational
timing is diﬀerent among species, occurring before MPF activation in Xenopus (however, Mos protein is unstable until GVBD and MAPK
activity is detected only at time of MPF activation, not illustrated) and during metaphase I in other species.
4.2. Control of Mos Stability. Even though the synthesis
of Mos begins soon after progesterone stimulation in
Xenopus oocytes, the protein remains unstable and unable
to activate MAPK until MPF activation [33, 72, 73]. The
polyadenylation-controlled translation of Mos is an early
event but is not suﬃcient for Mos to accumulate. Several
studies attempted to elucidate the molecular mechanisms
that govern the metabolic stability of Mos during meiotic
maturation. Using a number of Mos mutants expressed in
Xenopus oocytes, Nishizawa et al. [33, 74] demonstrated
that the instability of Mos depends on the ubiquitination
of Lys34 and is determined primarily by its penultimate N-
terminalresidue,aproline,andthephosphorylationstatusof
the adjacent serine (Ser3) residue. Clearly, Mos is stabilized
by phosphorylation at Ser3, its major phosphorylation site
in vivo [17]. This critical phosphorylation for Mos stability
is catalyzed by MPF kinase activity, which probably acts
to prevent the N-terminus of Mos from being recognized
by its ubiquitin ligase [33, 74, 75]. Similarly in mouse,
the phosphorylation of Ser16 prevents Mos degradation
and stabilizes the protein [76]. The unique role of Mos
phosphorylationwouldbetostabilizetheprotein.Therefore,
while the Mos/MAPK pathway can facilitate the activation
of MPF, MPF is required to directly phosphorylate and
stabilize Mos protein, a mechanism creating a positive
feedback loop between Mos and MPF. Importantly, these
results reconcile some apparent conﬂicting conclusions on
Mos functions in Xenopus and mouse. In both cases, Mos
activity can take place only after MPF activation and meiosis
reentry: the protein needs to be stabilized by MPF despite
an early translational initiation in the frog oocyte, while
it is only synthesized after MPF activation in the mouse
oocyte.
4.3. Control of Mos Degradation at Fertilization. In all species
studied until now, fertilization induces a rapid escalation
in intracellular calcium ion concentration that releases
the meiotic arrest. Interestingly, Mos was proposed to be
the cytostatic factor responsible for meiotic arrest of the
unfertilized oocytes [12] and was shown to undergo speciﬁc
proteolysis upon fertilization when the arrest is relieved
[7, 77]. However, in both Xenopus and mouse oocytes, Mos
disappearance at fertilization starts 30 to 45 minutes after the
calcium surge [7, 77, 78], whereas MPF inactivation occurs
within 15 minutes through cyclin B degradation (Figure 2).
Clearly,thedegradationofMosatfertilizationisnotrequired
for cyclin B proteolysis and is, therefore, not the inducer of
the release of the meiotic arrest but rather a consequence of
t h i se x i t[ 79]. To summarize, Mos is essential for establishing
and maintaining the meiotic arrest; the release of this arrest
at fertilization is due to a mechanism that overcomes Mos
but is not a consequence of Mos degradation. In Xenopus
oocytes, MPF ensures Mos stability by phosphorylating its
Ser3 residue. At fertilization, cyclin B is rapidly degraded,
leading to the inactivation of MPF and consequently the
dephosphorylation of Mos. Under this unphosphorylated
state, Mos is then degraded by a yet unidentiﬁed ubiquitin
ligase, diﬀerent from the anaphase-promoting complex-
cyclosome (APC/C) that targets several cell-cycle regulatory
proteins, including cyclin B, for destruction [33, 74, 75].
However, the destruction of Mos under the control of
MPF appears to be speciﬁc to vertebrate oocytes that are
arrested in M-phase. It would be important to evaluate
how unfertilized eggs of invertebrates, arrested after meiosis
completion in G1, get rid of Mos, an essential event to
prevent the organism from the oncogenic activity of this
protein.Journal of Signal Transduction 7
5. Which Functions for Mos in Oocytes?
5.1. Mos as an Initiator for Oocyte Maturation? The very ﬁrst
studies on the physiological function of Mos were conducted
on the Xenopus oocytes and revealed that injection of Mos
antisense oligonucleotides blocks GVBD and MPF activation
whereas the injection of Mos RNA activated MPF and
induced GVBD in the absence of progesterone [6, 11]. In
contrast to mouse or starﬁsh, a period of protein synthesis
is necessary for MPF activation in the frog oocyte [80].
Yew et al. [81] reported that Mos protein eﬃciently induces
GVBD and the activation of MPF in the absence of protein
synthesis (but in the presence of low concentrations of
progesterone unable to trigger meiotic maturation), leading
to the conclusion that Mos is the only synthesized protein
required for initiating maturation. All constitutively active
downstream eﬀectors of Mos, MEK, MAPK, and p90Rsk,a r e
also able to induce meiotic maturation when microinjected
into oocytes [82–84]. The eﬀects of Mos on MPF activation
are mediated through MEK/MAPK/p90Rsk, as microinjected
Mos is inactive in the presence of the pharmacological MEK
inhibitor,U0126[85].Altogether,theseresultsledtoasimple
scenario, where MPF activation is the result of a linear chain
of molecular events initiated by progesterone, starting with
thesynthesisofMosprotein,thesubsequentactivationofthe
MEK/MAPK/p90Rsk cascade that would eventually control
the two regulators of the Cdk1 catalytic subunit of MPF, the
Myt1 kinase that phosphorylates and inactivates Cdk1 and
the Cdc25 phosphatase that speciﬁcally activates Cdk1 [86–
88].
However,thissimpleviewwasthenquestionedbyseveral
studies.Grossetal.andFisheretal.showedthatprogesterone
is able to activate MPF by a mechanism independent of
MAPK [85, 89]. This conclusion is diﬃcult to reconcile
with a requirement for Mos downstream of progesterone
in Xenopus oocyte. Consistent with the idea that MAPK
activation downstream of Mos synthesis is not required for
maturation, inhibition of Mos synthesis by morpholino anti-
sense oligonucleotides fails to block progesterone-stimulated
GVBD [90]. This conﬂicting results on the requirement
of the Mos/MAPK cascade to activate MPF in Xenopus
oocyte were recently reconciled. It was shown that MPF
activation induced by progesterone is completely abolished
when cyclin B synthesis and the Mos/MAPK pathway are
simultaneously impaired [88]. The replenishment of at least
one of these pathways restores MPF activation. Altogether,
these results demonstrate that MPF activation requires
either the Mos/MAPK pathway or cyclin B synthesis. Each
of these pathways can bypass the deﬁciency of the other
one. In contrast to cyclin B1 accumulation induced by
progesterone independently of MPF activation, the strong
accumulation of Mos requires a stabilizing phosphorylation
catalyzed by MPF [73, 75] and as a consequence MAPK
activation only takes place when MPF activation is already
initiated. This diﬀerential regulation in the accumulation of
Mos and cyclin B1 suggests that the physiological pathway
induced by progesterone depends on cyclin B synthesis and
that the Mos/MAPK cascade contributes to MPF activation
once Mos stabilization is achieved. When cyclin B syn-
thesis is impaired, some rescue mechanism could recruit
the Mos/MAPK pathway, allowing it to complement the
deﬁciency in cyclin B synthesis. These ﬁndings solve the
paradoxical situation of the frog oocyte meiotic reentry
control, where the Mos/MAPK activation was considered
as necessary for MPF activation, while this is clearly not
the case in all other systems studied until now (mouse,
starﬁsh, jellyﬁsh, Drosophila, and C. elegans, where Mos is
not expressed yet at the time of MPF activation, Figure 2)
and integrates the Xenopus in the context of a universal
mechanism for meiotic maturation in oocytes throughout
the animal kingdom.
5.2. Suppression of DNA Replication and Entry into Meiosis II.
In Xenopus, the ability to replicate DNA is acquired during
maturation at the beginning of meiosis I by synthesis of
the only missing replication factor, Cdc6, which is essential
for recruiting the minichromosome maintenance (MCM)
helicase to the prereplication complex [91, 92]. After GVBD,
the maturing oocyte is thus fully equipped with a functional
replication machinery that has to be inhibited to prevent
the entry into S-phase until fertilization. In Xenopus, Mos
has been shown to be required during the metaphase I
to metaphase II transition to suppress S-phase. When the
synthesis or the activity of Mos is speciﬁcally inhibited or
when MAPK activation is prevented by U0126, Xenopus
oocytes complete meiosis I but a nuclear envelope reforms
and DNA replication occurs [85, 90, 93]. Essentially similar
results have been obtained in starﬁsh oocytes [8]. However,
in mouse oocytes, conﬂicting results have been obtained
concerning the involvement of Mos and MAPK in S-phase
suppression and entry into meiosis II. The ablation of Mos
by antisense oligonucleotides either arrests oocytes before
extrusion of the ﬁrst polar body [4] or induces nuclear
reformation and DNA replication after meiosis I [94, 95], as
in Xenopus. In contrast, oocytes from the mos gene knockout
mice enter meiosis II essentially normally, despite going
through an interphase-like microtubular stage [13, 14, 38].
The reasons for these conﬂicts could be due to diﬀerences
in the strains of mice used or to the experimental strategy
used for deletion. In jellyﬁsh oocytes where Mos is ablated
by morpholino antisense or MAPK activation is inhibited by
U0126, GVBD occurs on time, but oocytes show a complete
failure to emit both ﬁrst and second polar bodies. However,
they do not reform a replicating nucleus [9]. Then, the
ability of Mos to suppress DNA replication between the two
meiotic divisions of the oocyte is not a function universally
conserved. These diﬀerences could be related to the presence
or the absence of a functional replicative machinery in
oocytes, depending on the species. For instance, mouse
oocytes do not acquire the ability to replicate DNA before
metaphase II (and therefore do not need to suppress it), in
contrast to starﬁsh and Xenopus oocytes that develop the
ability to replicate DNA early after GVBD [8, 91–93].
Until now, the molecular mechanism controlled by the
Mos/MAPK cascade and leading to the inhibition of DNA
replication remains unclear. All the ﬁndings support the
view of a critical function of Mos at meiosis I-meiosis II8 Journal of Signal Transduction
transition in vertebrates: the Mos/MAPK module is involved
in MPF reactivation that depends both on the arrest of
cyclin B degradation, initiated at the exit of meiosis I,
and on new cyclin B synthesis, allowing MPF reactivation
and entry into meiosis II [85, 90, 93, 96]. By controlling
this cyclin B turn-over, Mos allows MPF activation and
entry into meiosis II. The Mos/MAPK module could act
indirectly on the replication machinery through the control
of MPF activity. Since quite similar failure of the meiosis
I/meiosis II transition occurred in Xenopus oocytes that
were injected either by antisense against Mos mRNA or
dominant-negative Cdk1 kinase [93], it was suggested that
MPFreactivationoccurringunderthecontrolofMos/MAPK
after meiosis I would suppress DNA replication. However,
when the reactivation of MPF at meiosis II is inhibited
speciﬁcally by antisense oligonucleotides against B-cyclins,
theXenopus oocytesdegenerate,failtoformasecondmeiotic
spindle, but do not support nuclear organization and DNA
replication [96]. This careful analysis favors the view that
the Mos/MAPK pathway acts directly to suppress DNA
replication, independently of MPF activity.
A conserved function for Mos revealed by observations
in the oocytes of starﬁsh, mouse, Xenopus, and the jellyﬁsh
Clytia is its involvement in the control of spindle forma-
tion and positioning and the chromatin organization. This
was ﬁrst revealed by analysis of mouse oocytes [38, 97,
98]. Remarkably in mos−/− oocytes or in oocytes where
MEK is inhibited, the microtubules and chromosomes
evolve towards an interphase-like state during the transition
between two meiotic M-phases and then exhibit monopolar
half-spindles [38, 97–99]. Later on, similar observations
were performed in other systems [8, 9, 39]. This ancient
and conserved role of the Mos/MAPK in the modulation
of microtubular cytoskeleton to assure meiotic spindle
formation and positioning could contribute to its cytostatic
activity independently on the control of MPF in oocytes
arrested at metaphase I (as Drosophila) or metaphase II
(as in mouse, see next paragraph). It could also contribute
to the chromosome instability of tumor cells where mos is
upregulated [100].
5.3. The Meiotic Arrest of the Unfertilized Oocyte: A Conserved
Function of Mos. In all animals, oocytes halt meiosis to
prevent embryonic development in the absence of fertiliza-
tion. The stage of meiosis at which the oocyte (also called
“egg” in species where meiotic divisions are completed, as
echinoderms and cnidarians) typically arrests varies depend-
ing species: metaphase II in vertebrates, metaphase I in
insects, molluscs, and ascidians, G1 phase following meiosis
in echinoderms and cnidarians, prophase I in nematodes
(Figure 1). Surprisingly, given the diversity of stages where
the cell cycle is halted, Mos was found to be the ubiquitous
cytostatic factor responsible for the unfertilized oocyte arrest
throughout the animal kingdom.
5.3.1. Metaphase II Arrest in Vertebrates. The activity respon-
sible for this arrest was ﬁrst described in 1971, by injecting
extracts derived from metaphase II-arrested oocytes into
one blastomere of a 2 cell-stage Xenopus embryo [12, 43].
The injected blastomere arrests at the next mitosis with a
metaphase spindle and a high MPF activity. On the basis
of these observations, Masui and Markert established the
existence of an activity called CSF (cytostatic factor) that
is responsible for metaphase II-arrest. Using this assay,
Sagata et al. [12] proposed that Mos is a cytostatic factor
responsible for meiotic arrest in vertebrate eggs. Since then,
the downstream targets of Mos, MEK, MAPK, and p90Rsk
were also shown to cause an M-phase arrest when injected
in a Xenopus dividing blastomere [101–104]. The ability of
Mos to confer a CSF arrest is abrogated when MAPK activity
is prevented [101, 104, 105]. Conversely, any upstream
activator of MAPK is able to induce a CSF arrest, as the
small G protein Ras or the kinase Raf [106, 107]. These
results suggest that the metaphase II-arresting CSF activity
of Mos is largely mediated by MAPK. Nevertheless, the
physiological validation of the Mos/MAPK pathway as CSF
came from the deletion of Mos in oocytes. Ablating Mos
synthesis by an antisense strategy in Xenopus oocytes induces
cell cycle oscillations after meiosis I, mimicking the early
embryonic cell cycles [90]. Invalidating the mos encoding
gene in mouse leads to a failure of mature oocytes to arrest
during meiosis and as a consequence to parthenogenetic
activation of unfertilized oocytes [13, 14, 38].
Invertebrates,theMos/MAPKpathwayservestostabilize
MPF, ensuring an arrest at the metaphase stage. Releasing
thisblockagerequirestheactivityoftheAPC/Cproteincom-
plex, a ubiquitin ligase that targets cyclin B for destruction
[108, 109]. In mouse and Xenopus metaphase II-arrested
oocytes, APC/C is directly inhibited by the Erp1/Emi2 pro-
tein [110]. During oocyte maturation, Erp1/Emi2 appears
only after metaphase I, explaining why the oocyte does not
stop at metaphase I, but at metaphase II [111, 112]. Upon
fertilization, a transient rise in free intracellular calcium
activates calmodulin-dependent protein kinase II that phos-
phorylates Erp1/Emi2, thereby creating a docking site for the
Polo kinase. The Erp1/Emi2 phosphorylation by Polo kinase
targets it to destruction, releasing APC/C from inhibition
[110, 113, 114]. As a consequence, cyclin B is degraded,
MPFactivityisthusinactivatedandthefertilizedoocyteexits
metaphase II. Given that Erp1/Emi2 can itself inhibit APC/C
and stabilize MPF, why is the Mos/MEK/MAPK/p90Rsk
required for metaphase II arrest? Recent works provided
promising clues about the relationships between Mos
and Erp1/Emi2. In Xenopus metaphase II-arrested oocytes,
Erp1/Emi2 is a substrate of p90Rsk, and Mos-dependent
phosphorylation of Erp1/Emi2 by p90Rsk is crucial for both
stabilizing Erp1/Emi2 and establishing CSF arrest in meiosis
II oocytes [115, 116]. More precisely, the Rsk-mediated
phosphorylation of Erp1/Emi2 promotes its interaction with
the protein phosphatase PP2A. PP2A dephosphorylates two
distinct clusters of residues in Erp1/Emi2, one responsible
for modulating its stability during the metaphase II-arrest
and one controlling its binding to the APC/C [112, 117,
118].Thus,MosandErp1/Emi2collaborativelyestablishand
maintain metaphase II arrest in Xenopus oocytes (Figure 3).
In mouse, the APC/C Erp1/Emi2 also plays a critical role
for maintaining the metaphase II-arrest of the unfertilizedJournal of Signal Transduction 9
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Figure 3: Meiotic arrest of the unfertilized oocyte: the downstream eﬀectors of Mos/MAPK. In all species, oocytes halt meiosis to prevent
embryonicdevelopment intheabsenceoffertilization.Depending onspecies,meiosisarrestsatprophaseI,metaphaseI,metaphaseII,orG1
following meiosis. Except in C. elegans, Mos was found to be the ubiquitous cytostatic factor responsible for the unfertilized oocyte arrest.
Its downstream targets accounting for the meiotic arrest of the unfertilized oocytes are indicated.
oocyte [119, 120]. Therefore, it would be logical to predict
that the mechanism of metaphase II-arrest establishment is
also conserved between frog and mouse. However, this is
not so. Surprisingly, although it is well established that the
Mos and MAPK are essential for establishing this arrest,
p90Rsk, which is activated by MAPK as in the other species
[121], is not involved in the metaphase II-arrest of mouse
oocytes [122]. This is in strong contrast with Xenopus or
starﬁsh unfertilized oocytes, where it is the main mediator
of Mos cytostatic activity (see before and below). Then, the
downstream eﬀector of MAPK regulating APC/C through
Erp1/Emi2 and/or stabilizing the microtubular spindle still
requires to be elucidated in mouse.
5.3.2. G1 Arrest in Starﬁsh and Jellyﬁsh. In contrast to
vertebrates whose oocytes arrest at metaphase II to await
fertilization, unfertilized eggs of starﬁsh are blocked at G1
phase after completion of meiosis II. In the absence of
Mos, meiosis I is directly followed by repeated embryonic
mitoticcyclesinstarﬁsh[8].Therefore,despitethediﬀerence
in the arrest stage between vertebrates and starﬁsh, both
arrests depend on the same Mos-MAPK pathway, indicating
that the diﬀerence relies on particular downstream eﬀectors.
Inhibition of p90Rsk activity in the starﬁsh unfertilized
egg leads to S-phase in the absence of fertilization [123],
indicating that the eﬀects of Mos on the meiosis arrest
are mediated, at least partially, through its downstream
eﬀector, p90Rsk,a si nXenopus oocyte. In starﬁsh G1-arrested
eggs, chromatin is loaded with the MCM complex to form
the prereplicative complex. p90Rsk blocks S-phase entry by
preventing the further loading of Cdc45 onto chromatin to
form the preinitiation complex and the subsequentinitiation
of DNA replication [124] (Figure 3). However, the S-phase
induced by p90Rsk inhibition is not followed by M-phase
when MAPK remains active, owing to repression of cyclin
A and B synthesis (Figure 3). By contrast, inactivation of
MAPK alone induces M-phase. Thus, there is a divergence of
separate pathways downstream of MAPK that together block
the initiation of the embryonic mitotic cycle. One depends
on p90Rsk and prevents S-phase, the other is not mediated
by p90Rsk and leads to the prevention of the ﬁrst mitotic
M-phase through suppression of mitotic cyclin synthesis
(Figure 3). Release from this dual lock by fertilization results
in the start of the embryonic cell cycle [125].
In the jellyﬁsh Clytia hemispherica as in starﬁsh, unfer-
tilized eggs are blocked in G1 phase after meiotic division
completion and the invalidation of the Mos/MAPK pathway
leads to parthenogenetic development with complete cleav-
ages,revealingthattheMos/MAPKfunctioninmeioticarrest
is conserved through the animal kingdom [9].
5.3.3. Metaphase I Arrest. In many invertebrates, as insects,
molluscs, and ascidians, oocytes arrest at metaphase I. At
ﬁrst glance, it is tempting to speculate that the molecular
basis of this arrest could resemble those operating during
the metaphase II-arrest in vertebrates oocytes, based on
the Mos/MAPK pathway as an upstream regulator of cyclin
B stabilization through APC/C inhibition. This is not
so. The Drosophila homolog of Mos has been identiﬁed
and is expressed speciﬁcally in oocytes. As in vertebrates,
Mos is responsible for the majority of MAPK activation
that occurs during meiotic maturation. Unexpectedly, the
oocytes with a Mos deletion complete meiosis normally and
produce fertilized embryos that develop [41]. Therefore,
the Drosophila Mos ortholog would not be essential for
meiosis. Some innovation in oocyte function could explain
the relaxation of the cytostatic role of Mos in Drosophila,
as the adoption of internal fertilization that could reduce
the delay between meiotic completion and fertilization. It
has also to be noticed that the mechanism by which the
metaphase I arrest is maintained and released is particularly
intriguing in Drosophila. It has been demonstrated that
chiasmata are essential for signaling the arrest [126, 127],
but the role of MPF remains unknown. Then, the molecular10 Journal of Signal Transduction
mechanismsunderlyingthemetaphaseIarrestcouldregulate
very diﬀerent targets from those identiﬁed in other species.
In the parthenogenetic insect Athalia rosae, the Mos/MAPK
module arrests the unfertilized oocytes at metaphase I [128].
Therefore, the role of Mos in Drosophila oocyte cannot be
extrapolated to all insects (Figure 3).
The oocytes of the ascidian Ciona intestinalis merge as
a new model to study the meiotic divisions. The Mos/MAP
kinase pathway is perfectly conserved in ascidians and
metaphase I-arrested oocytes of C. intestinaliscontain a CSF-
like activity able to block cell division in two-cell embryos
[129]. MAPK might ensure this activity [130], suggesting
that meiotic arrest in C. intestinalis could resemble that of
vertebrates, such as Xenopus, accordingly to the position of
this organism in the evolutionary tree (Figure 3).
5.3.4.C.elegans:MeioticArrestwithoutMos. TheCaenorhab-
ditis elegans nematode has secondarily lost the mos gene. In
this worm, MAPK is activated at two separate steps during
the oocyte meiotic cell cycle, under the control of the small
G protein Ras and the kinase Raf that replaces Mos [131,
132]. It is ﬁrst stimulated in the pachytene stage of meiotic
prophase I, where it is required for the progression through
pachytene. MAPK is then inactivated rapidly after pachytene
and remains inactive throughout diakinesis, which is the
point of prophase arrest in C. elegans oocyte. The prophase
arrest is relieved by a maturation signal produced by the
sperm that leads to MAPK reactivation [133]. Interestingly,
maintaining MAPK in an inactive state after pachytene exit
is necessary to allow the developing oocytes to arrest the
cell cycle in diakinesis until maturation is induced by the
spermsignal.OocyteswithaconstitutiveMAPKactivityafter
pachytene completion are unable to arrest in diakinesis for a
prolonged time, and they enter a mitotic cell cycle without
being fertilized [134]. Therefore, despite the lack of mos
gene in C. elegans, MAPK exerts a function during meiosis,
being required in oocytes to coordinate meiosis progression
with fertilization. However, instead of playing the usual
cytostaticrole,activeMAPKisnecessarytobreakthemeiotic
arrest where the C. elegans oocyte is awaiting fertilization
(Figure3).Thisobservationisnotsosurprisinggiventhefact
that the arrest where the C. elegans oocyte awaits fertilization
corresponds to the universal arrest, where oocytes await
the meiotic maturation signal, prophase I, characterized
by the absence of Mos expression through all the animal
kingdom.
6. Concluding Remarks
Since the discovery of the meiotic functions of Mos about
20 years ago, there has been many studies exemplifying the
apparently conﬂicting eﬀects of the Mos protein, namely,
its ability to induce M-phase entry of oocytes, its ability to
arrest the meiotic cell cycle at various stages, and its ability
to transform mammalian ﬁbroblasts. As reviewed here, these
studies can be easily reconciled when taking into account
three characteristics of Mos that distinguish it from the main
somatic regulators of MAPK, as Raf-1.
First, Mos activates MAPK independently of the presence
of serum, growth factors, and tyrosine kinase receptor
activation. In this regard, it acts like a dominantly acting
oncogene.
Second, its kinase activity is not regulated by post-
translational modiﬁcations. Once the protein is expressed,
it is active. The regulation of its expression, depending on
translation and degradation, determines where and when it
will function.
Third, Mos appeared early during animal evolution
as a speciﬁc oocyte-expressed kinase. A particularity of
full-grown oocytes is that transcription of genes is silent:
transcriptional activities stop at the end of the growth
period and are reinitiated in the cleaving embryos, after
fertilization. In this oocyte physiological background, even if
the Mos-MAPK pathway would phosphorylate and activate
transcription factors, this would not induce transcription of
any genes in the oocyte.
From these observations, the apparent conﬂicting nature
of Mos, acting physiologically as a tumour-supressor gene
in the unfertilized oocyte, and as an oncogene when inap-
propriately expressed in somatic cells, seems to be basically
resolved: the functions played by Mos depend on the identity
of the ﬁnal MAPK targets that are at its disposal.
When expressed in somatic cells, MAPK activated by
Mos can phosphorylate and stabilize transcription factors
as c-Fos and c-Myc, leading to transcriptional induction of
critical oncogenes and cellular transformation [135, 136].
Clearly, this cannot happen in oocyte where transcription is
inactive. It is also probable that Mos can impose a meiotic-
like phenotype on all stages of the somatic cell cycle. In
particular, its meiotic regulatory activities concerning the
formation of microtubular spindles, the cohesion of sister
chromatids and the omission of S-phase, could participate to
the chromosome instability characterizing malignant clones
where meiotic genes as mos are induced [100].
Physiologically, Mos functions in regulating core special-
izations of female meiosis. Asymmetric spindle positioning
and polar body emission as well as cytostatic arrest are
the ancestral functions of Mos for Eumetazoa. Interestingly,
despite the diﬀerences in the meiotic arrest stages of
unfertilized oocytes among species, all of them are under the
control of Mos, indicating again that the diﬀerences rely on
particular downstream targets of MAPK. If the translational
regulation of Mos is modiﬁed, in time or in space, Mos can
acquire new roles by ﬁnding new targets. This scenario could
have operated in the oocyte during evolution, for example,
after sequence changes in its UTRs aﬀecting translation
timing.
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